Access brought to you by: LOCKSS

Diabetes Mellitus

Ranolazine Provides Benefit over Placebo for T2DM Patients with Angina
Impact of LX4211 on Cardiovascular Risk Factors in Type 2 Diabetes
The FREEDOM Trial: CABG Superior to PCI in Diabetic Patients with CAD
DiaPep277® Shows Promise as a Therapeutic Strategy for Type 1 Diabetes
12-Week Treatment with LY2409021 Significantly Lowers HbA1C and Is Well Tolerated in Patients with Type 2 Diabetes Mellitus
Insulin Degludec is Superior to Sitagliptin in Improving Glycemic Control in Uncontrolled Patients with Type 2 Diabetes on Oral Agents
Population-Based Screening for Type 2 Diabetes: The ADDITION-Cambridge Trial
The Challenges of Pharmaceutical Management of Painful Diabetic Peripheral Neuropathy
Diabetes and Enterovirus Infection: The Evidence and Implications
Novel Oral Agents: The Search for Transformational Medicines

Pages